Scientists have identified a new subtype of depression that may be affecting as many as one in four patients, a discovery that could lead to new medical and behavioural treatments.
This could explain why traditional antidepressant treatments such as selective serotonin reuptake inhibitors (SSRIs) do not work well for some people.
